Home › Funds › APEIRON CAPITAL Ltd › SMMT
APEIRON CAPITAL Ltd position in SMMT
SUMMIT THERAPEUTICS INC · Health Care
APEIRON CAPITAL Ltd reported holding 961,866 shares of SMMT (SUMMIT THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$14.0M, representing 9.00% of its reported portfolio and ranking #5 among its reported holdings. APEIRON CAPITAL Ltd has disclosed SMMT holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How APEIRON CAPITAL Ltd's SMMT position evolved
APEIRON CAPITAL Ltd first disclosed a stake in SMMT in Q2 2025 at 1,200,941 shares (US$23.2M). The position peaked in Q3 2025 at 1,310,941 shares, worth US$27.1M. Across 5 filings, APEIRON CAPITAL Ltd increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 961,866 shares valued at US$14.0M — a reduction of -347,275 shares quarter over quarter.. Notable position changes include a 27% trim in Q2 2026 (shares rose 16% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 1.20M | $23.17M | New |
| Q3 2025 | 1.31M | $27.08M | Add |
| Q4 2025 | 1.31M | $22.90M | Hold |
| Q1 2026 | 1.31M | $24.82M | Hold |
| Q2 2026 | 961.87K | $14.01M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SMMT and 13F data
SMMT (SUMMIT THERAPEUTICS INC) is a Health Care company. 46 other funds we track also report a position in SMMT — the largest reported positions include BAKER BROS. ADVISORS LP (US$477.7M), Logos Global Management LP (US$19.7M), Octagon Capital Advisors LP (US$18.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SMMT
- BAKER BROS. ADVISORS LP 32.79M sh · $477.70M · Q2 2026
- Logos Global Management LP 1.35M sh · $19.67M · Q2 2026
- Octagon Capital Advisors LP 1.25M sh · $18.21M · Q2 2026
- Kynam Capital Management, LP 1.20M sh · $17.48M · Q2 2026
- Elmind Capital, LP 493.82K sh · $7.19M · Q2 2026
More on APEIRON CAPITAL Ltd
FAQ
How long has APEIRON CAPITAL Ltd held SMMT?
APEIRON CAPITAL Ltd has disclosed SMMT holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is APEIRON CAPITAL Ltd's current position in SMMT?
As of Q2 2026, APEIRON CAPITAL Ltd holds 961.87K shares of SMMT (SUMMIT THERAPEUTICS INC), valued at $14.01M, representing 9.00% of its reported portfolio and ranking #5.
Has APEIRON CAPITAL Ltd been buying or selling SMMT?
In the latest 13F filing (Q2 2026), APEIRON CAPITAL Ltd reduced its position in SMMT. The position peaked in Q3 2025 at 1.31M shares.
Which other funds hold SMMT?
Other major institutional holders of SMMT include BAKER BROS. ADVISORS LP, Logos Global Management LP, Octagon Capital Advisors LP, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.